Roslin Technologies Raises £11M in Series A Funding

Roslin Technologies, an Edinburgh, UK-based food and ag tech company, raised £11M in Series A funding.

The round was led by Novo Holdings, with participation from Kairos Capital Group, Nutreco, Future Planet Capital, Esco Lifesciences, and Alchimia. Nis Bak from Novo Holdings joined the board of Roslin Tech. This adds to funding received in 2021-2022 from Scottish Enterprise and existing shareholders including the University of Edinburgh’s venture capital fund, Old College Capital, and Future Planet Capital’s BIF Opportunities LP.

The company intends to use the funds to accelerate growth, expand its cell line portfolio, further develop the protocols for scaling up of its cells, and invest in its insect venture.

Led by CEO Ernst van Orsouw, Roslin Tech is a food and ag tech company whose core capabilities lie in developing and commercialising animal stem cells for the nascent global cultivated meat industry. The company has developed pluripotent animal stem cells with the capacity to self-renew indefinitely and differentiate into desired end-tissues for meat and is making these cells available to cultivated meat producers globally. Currently, Roslin Tech has customers in North America, Europe, Asia and the Middle East. The company was founded in 2017 as a venture between two investment firms and the University of Edinburgh from which it has certain rights to commercialize intellectual property from the University’s Royal School of Veterinary Studies and the Roslin Institute, a global leader in animal science.